CClinicalTrials.gg
Not yet recruitingNCT06184815Updated Dec 28, 2023

Effectiveness of a Multidisciplinary Treatment and Structured Education Programme

An interventional study of Educational programme 12 and Standard education and treatment in Type 1 Diabetes, sponsored by Instituto Mexicano del Seguro Social. Not yet recruiting. Open to participants aged 15 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-12-28.

Sponsored by Instituto Mexicano del Seguro Social · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Non-randomized
Ages
15 Years to 75 Years
Sex
All
01

Study summary

This trial compared an structured education programme and multidisciplinary treatment vs an standard treatment in type 1 diabetes patient, the Primary outcome is glycemic control at 6-month follow up and secondary outcome are cardiovascular risk factors control, diabetes related distress, anxiety and depressive symptoms, hypoglycemia awareness.

Read the detailed description

Both groups will received individualized treatment in the clinic, the intervention group will consist of 12 educational sessions during 4 months, and multidisciplinary treatment each month given by endocrinology, nutrition and psychology during 4 months, the control group will received education in outpatient clinic of endocrinology and will be sent as referral to specialties of nutrition and psychology as standard follow-up of the clinic.

02

Conditions studied

  • Type 1 Diabetes

Keywords

  • type 1 diabetes
  • Autoimmune Diseases
  • Diabetes
  • Education Programme
  • DSMES
  • Diabetes self-management education and support
  • T1D
  • Insulin-dependent diabetes
  • Juvenile diabetes
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 120 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Instituto Mexicano del Seguro Social is the lead sponsor of 124 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Type 1 diabetes
  • Diabetes duration >1 year
  • BMI 18.5-40kg/m2
  • A1c 6.5-13%

Exclusion criteria

Exclusion Criteria:

  • Pregnancy
  • Dementia or severe cognitive impairment
  • Uncontrolled psychiatric disorder
  • Absence of >20% of the educational sessions
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Educational programme 12

    The educational programme consists of 12 lessons, diabetes education slides and patient materials, with a duration of 4 months. The multidisciplinary treatment consists of 4, each one every month, consultations of specialties of nutrition, endocinrology and psychology.

    Behavioral: Educational programme 12

  • Active comparator
    Standard

    The standard educational program consists of outpatient management with diabetic education slides and material for the patient, with a duration of 4 months. Standard treatment consists of endocrinology consultation with nutrition and psychology referral if required

    Behavioral: Standard education and treatment

Interventions

  • BehavioralEducational programme 12

    Consists of 12 lessons, diabetes education slides and patient materials, with a duration of 4 months and multidisciplinary treatment

  • BehavioralStandard education and treatment

    Outpatient management and education in the office and consultation referral to nutrition and psychology

    Also known as: Standard

06

What researchers measure

Primary outcomes

  1. Changes in Glycemic Control Measured by A1c

    Difference between baseline A1c and A1c at 6 month follow up

    Time frame: Baseline and 6 months

Secondary outcomes

  1. Changes in Lipid Control Measured by LDLc, HDLc, non-HDLc, Triglycerides, Total Cholesterol

    Difference between basal lipid profile and lipid profile at 6 month follow up

    Time frame: Baseline and 6 months

  2. Changes in insulin resistance control Measured by eGDR

    Difference between basal eGDR and eGDR at 6 month follow up

    Time frame: Baseline and 6 months

  3. Changes in Mental health Measured by DDS, GAD7 and PHQ9

    Difference between basal DDS, GAD7 and PHQ9 and DDS, GAD7 and PHQ9 at 6 month follow up

    Time frame: Baseline and 6 months

  4. Changes Anthropometry Measured by BMI and WC

    Difference between basal BMI and WC and BMI and WC at 6 months

    Time frame: Baseline and 6 months

  5. Changes in Glycemic Control Measured by severe hypoglycemia

    Difference between severe hypoglycemia in the las 6 months and severe hypoglycemia at 6 months of follow up

    Time frame: Baseline and 6 months

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 28, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06184815
Lead sponsor
Instituto Mexicano del Seguro Social
Responsible party
David Sanchez Garcia (Principal investigator, Instituto Mexicano del Seguro Social) — Principal investigator
First posted
Dec 28, 2023
Start date
Jan 1, 2024 (estimated)
Primary completion
Nov 1, 2024 (estimated)
Completion
Nov 30, 2024 (estimated)
Last update
Dec 28, 2023

Study contacts

David Sanchez, MD
Contact
davidsanchez70@hotmail.com
8183714100 ext. 41315
David Sanchez, MD
principal investigator · Centro Médico Nacional del Noreste Hospital de Especialidades UMAE 25 Monterrey, Mexico

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion